Developing Effectiveness Evaluation and Therapeutic Programs of Rehabilitation

NCT ID: NCT03979235

Last Updated: 2025-05-23

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

40 participants

Study Classification

OBSERVATIONAL

Study Start Date

2019-06-05

Study Completion Date

2026-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Using robotics, sensors, and sEMG to develop clinic-oriented quantitative effectiveness evaluation and individualized programs of rehabilitation

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Using robotics, sensors, sEMG or other methods to develop clinic-oriented quantitative effectiveness evaluation and individualized programs of rehabilitation

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Healthy Volunteers Motor Deficits Dysphagia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Heahlthy people

perform motor function assessment by using scales, sEMG, and inertia sensors

Motor function assessment

Intervention Type DIAGNOSTIC_TEST

perform motor function assessment by using scales, sEMG, and inertia sensors

People with motor deficits

perform motor function assessment by using scales, sEMG, and inertia sensors

Motor function assessment

Intervention Type DIAGNOSTIC_TEST

perform motor function assessment by using scales, sEMG, and inertia sensors

Patients with dysphagia

perform motor function assessment by using scales, sEMG, and inertia sensors

Motor function assessment

Intervention Type DIAGNOSTIC_TEST

perform motor function assessment by using scales, sEMG, and inertia sensors

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Motor function assessment

perform motor function assessment by using scales, sEMG, and inertia sensors

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* no history of psychological/psychotic problems, no history of important diseases.


* patients with motor function impairment such as post stroke hemiplegia.

Exclusion Criteria

* history of psychological/psychotic problems


* cognitively or physically unable to cooperate with the examiner to finish the test
Minimum Eligible Age

18 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

National Research Center for Rehabilitation Technical Aids

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Pengxu Wei

Director

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

PX Wei, PhD

Role: PRINCIPAL_INVESTIGATOR

National Research Center for Rehabilitation Technical Aids

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

National Research Center for Rehabilitation Technical Aids

Beijing, , China

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

China

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

LT Wang, PhD

Role: CONTACT

86-10-58122882

PX Wei, PhD

Role: CONTACT

86-10-58122921

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

PX Wei, Dr.

Role: primary

86-10-58122921

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

20180104

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Reaching in Stroke 3rd Phase
NCT02912923 COMPLETED NA